Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Original Article from The New England Journal of Medicine — Effects of Intensive Glucose Lowering in Type 2 Diabetes. UKPDS overview. 1. The UK Prospective Diabetes Study ukpds; 2. • year multicenter RCT -Interventional Trial from to • Intensive.

Author: Akinogul Grolkree
Country: Trinidad & Tobago
Language: English (Spanish)
Genre: Science
Published (Last): 24 August 2006
Pages: 271
PDF File Size: 8.92 Mb
ePub File Size: 6.89 Mb
ISBN: 510-1-30384-585-6
Downloads: 8438
Price: Free* [*Free Regsitration Required]
Uploader: Akiktilar

The study has been successful and has shown that the complications of diabetes can be prevented by:. These showed that intensive management was neutral in its effect, with neither an adverse or beneficial effect. No threshold was seen, i. These also demonstrated a reduction in wstudio risk, including myocardial infarction [ 2021 ].

If not fatal they can seriously affect the quality of life. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ukpds In the world wide prevalence of uukpds 2 non-insulin dependent diabetes was 99 million 1.

There was a problem providing the content you requested

The same endpoint ascertainment and adjudication process was used throughout to ensure analytic comparability. Others were allocated to an intensive policy group aiming for near-normal glucose control, with two different sulphonylureas tablets or to insulin. Numerous substudies were embedded Figure 2the most notable being the Hypertension in Diabetes Study.

From setudio point of view of their age and racial mix, these people were representative of the typical British patient with Type 2 diabetes. Tight blood pressure control and dstudio of macrovascular and microvascular complications in type 2 diabetes.

Furthermore, the mortality in the group treated by sulphonylureas alone was unexpectedly low. Received Mar 15; Accepted Aug Intensive blood-glucose control by either sulphonylureas or insulin substantially decreases the risk of microvascular complications, but not macrovascular disease, in patients with type 2 diabetes.

In Type 2 diabetes diabetes, the major problem is complications from large artery disease and it has not hkpds known whether more intensive therapy would be helpful, particularly as there was concern about whether in the long term some therapies could themselves cause large vessel disease. Their use also reduced the number of treatment comparisons, thus minimizing the chances of false-positive results, but had the disadvantage of concealing the magnitude of effects on individual end points.


Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to esfudio duration, family practice, volume 32, issue 1.

One-third of patients allocated to tight control required three more drugs in eztudio attempt to achieve the target blood pressure. New methods of treating diabetes are still required. In the context of the suggested legacy effect of glucoselowering estueio in the 10year followup of the uk prospective diabetes study ukpds, the impact of the initial treatment in type 2 diabetes may be crucial in terms of longterm risk.

Diabetes mellitus is a multifactorial disease that requires longterm care since it involves. However, glucose levels usually remain high and these can lead to “diabetic complications”. UKPDS, ukpdx, confirmed that patients with Type 2 diabetes have a high incidence of heart attacks and strokes, and have a greater likelihood of early death than the general population.

There was no difference in HbA1c among agents in the intensive group. The followup studies of the diabetes control and complications trial dcct and the united estuio prospective diabetes study ukpds showed the longterm benefits of earlier periods of intensive glucose control with regards to macrovascular complications and mortality 24, New Engl J Med.

Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: These ukdps are valuable ammunition in the battle to improve services for patients. That the reduced occurrence of myocardial infarction was not significant may be due to type 2 statistical error.

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: These strengthened the study by broadening its scope, but at the cost of complicating the treatment allocation, conduct and analysis of the study.


estkdio The secondary aim of the study was to compare the effects of different treatments for diabetes, since some have theoretical advantages and disadvantages. The study showed that intensive blood glucose treatment is acceptable and that better blood glucose control could be obtained than with conventional management. A study on the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes.

UK Prospective Diabetes Study : Protocol

The study has also shown that after 10 years ulpds third have a complication that requires clinical attention, including heart attacks, strokes, laser treatment of the eyes, treatment for renal failure or amputations.

The study shows that this is not estuio case and that with good management, including improved blood pressure and blood glucose control, may help to make complications less common and no longer a half-expected outcome. There was no difference for any of the three aggregate endpoints between the three intensive agents chlorpropamide, glibenclamide, or insulin.

Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes ukpds The rates of major hypoglycaemic episodes per year were 0. The burden of type 2 diabetes Diabetes was first recognized years ago by the Ancient Egyptians. The results of UKPDS suggest that a formal screening programme should be set up to identify diabetes before symptoms occur.

In the study, patients were reviewed 3 monthly, rather than 6—12 monthly as in routine clinical practice, which has considerable resource implications.

Diabetes is the name given to a disease in which high blood glucose concentrations occur. A lowcarbohydrate, ketogenic diet to treat type 2 diabetes. Improved blood-glucose control decreases the progression of diabetic microvascular disease, but the effect on macrovascular complications is unknown.

Effects of enalapril on mortality in severe congestive heart failure.